SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Jul. 31, 2016

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

CANTEL MEDICAL CORP.

SCHEDULE II - VALUATION AND QUALIFYING ACCOUNTS

	Balance at										Balance
	Beginning								Translation		at End
	of Period		Additions			(Deductions)			Adjustments		of Period
Allowance for doubtful accounts:
Year ended July 31, 2016	$	2,092,000	$	15,000		$	(223,000)		$	(34,000)	$	1,850,000
Year ended July 31, 2015	$	1,874,000	$	464,000		$	(227,000)		$	(19,000)	$	2,092,000
Year ended July 31, 2014	$	1,265,000	$	706,000		$	(95,000)		$	(2,000)	$	1,874,000
Reserve for excess and obsolete inventory:
Year ended July 31, 2016	$	3,895,000	$	3,182,000		$	(1,569,000)		$	(118,000)	$	5,390,000
Year ended July 31, 2015	$	4,419,000	$	1,494,000		$	(1,796,000)		$	(222,000)	$	3,895,000
Year ended July 31, 2014	$	1,781,000	$	3,480,000		$	(802,000)		$	(40,000)	$	4,419,000
		.
Deferred tax asset valuation allowance:
Year ended July 31, 2016	$	2,037,000	$	929,000		$	(712,000)			80,000	$	2,334,000
Year ended July 31, 2015	$	3,538,000	$	1,010,000		$	(2,420,000)	(1)	$	(91,000)	$	2,037,000
Year ended July 31, 2014	$	308,000	$	3,363,000	(1)	$	(126,000)		$	(7,000)	$	3,538,000

(1)The amounts primarily include additions and deductions of valuation allowances associated with New Jersey net operating losses, as further explained in Note 10 to the Consolidated Financial Statements.